Aandeel CNBX CANNABICS PHARMACEUTICALS INC.
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren
Inactief instrument

Andere talen Cannabics Pharmaceuticals Inc. Other OTC

Aandelen

CNBX

US13764M1009

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
CNBX Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024
CNBX Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended November 30, 2023
CNBX Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended August 31, 2023
CNBX Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended May 31, 2023
BigTime Penny Stocks: Unusual "Chatter" Watchlist (GEGI, AAPJ, CNBX, GTVH)
BigTime Penny Stocks: Potential Breakout Stocks - Watchlist (GNPX, CLNV, CNBX, WOEN)
CNBX PHARMACEUTICALS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
CNBX Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 28, 2023
CNBX PHARMACEUTICALS INC. : Change in Directors or Principal Officers (form 8-K)
CNBX Pharmaceuticals Inc. Announces Board Resignations
CNBX PHARMACEUTICALS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
CNBX Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended November 30, 2022
CNBX PHARMACEUTICALS INC. : Change in Directors or Principal Officers (form 8-K)
Shaul Yemal Resigns Position as Director and Board Member Cnbx Pharmaceuticals Inc
CNBX PHARMACEUTICALS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)
CNBX Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended August 31, 2022
CNBX Pharmaceuticals Inc. Auditor Raises 'Going Concern' Doubt
CNBX to Enter the Cancer Immunotherapy Market After Acquiring a Controlling Interest in TaGeza Biopharma
CNBX Pharmaceuticals Inc. acquired unknown stake in TaGeza Biopharmaceuticals Ltd.
CNBX Files New PCT Patent Application For Cannabinoids-Based Neoadjuvant Cancer Therapy
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers CNBX
  4. Koers CNBX
  5. Nieuws Cannabics Pharmaceuticals Inc.
  6. Andere talen